Document Detail


Extended infusion of dexmedetomidine to an infant at sixty times the intended rate.
MedLine Citation:
PMID:  20885920     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Dexmedetomidine is an α2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe the hemodynamic, respiratory, and sedative effects of this overdose.
Authors:
Bryan A Max; Keira P Mason
Publication Detail:
Type:  Journal Article     Date:  2010-09-08
Journal Detail:
Title:  International journal of pediatrics     Volume:  2010     ISSN:  1687-9759     ISO Abbreviation:  Int J Pediatr     Publication Date:  2010  
Date Detail:
Created Date:  2010-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101517077     Medline TA:  Int J Pediatr     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Anesthesia, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting successful aging in a population-based sample of georgia centenarians.
Next Document:  Weight considerations in pharmacotherapy for type 2 diabetes.